# Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise

> **NCT00478972** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 321 (actual)

## Conditions studied

- Obesity
- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Rimonabant
- **DRUG:** placebo (for Rimonabant)
- **OTHER:** Diet and exercise

## Key facts

- **NCT ID:** NCT00478972
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 321 (ACTUAL)
- **Why stopped:** Company decision taken in light of demands by certain national health authorities
- **Last updated:** 2016-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00478972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00478972, "Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00478972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*